Intraoperative parathyroid hormone assay during focused parathyroidectomy: the importance of 20 minutes measurement

BMC Surgery

Angelo Nicolosi²  Matteo Atzeni²  Lucia Barca¹  Fabio Medas²  Giulia Loi²  Giuseppe Pisano²  Pietro Giorgio Calò² 

[1] School of Specialty in Clinical Pathology, University of Cagliari, Cagliari, Italy;Department of Surgical Sciences, University of Cagliari, Cagliari, Italy

关键词: Intra-operative PTH;    Parathyroidectomy;    Parathyroid hormone;    Primary hyperparathyroidism;   

Others  :  866902
DOI  :  10.1186/1471-2482-13-36

 received in 2013-03-29, accepted in 2013-09-17,  发布年份 2013

【 摘 要 】

Background

Parathyroid hormone (PTH) monitoring during the surgical procedure can confirm the removal of all hyperfunctioning parathyroid tissue, as the half-life of PTH is approximately 5 min. The commonly applied Irvin criterion is reported to correctly predict post-operative calcium levels in 96-98% of patients. However, the PTH baseline reference concentration is markedly influenced by surgical manipulations during preparation of the affected glands, interindividual variability of the PTH half-life and modifications in the physiological state of the patient during surgery. The aim of this study was to evaluate the possible impact of the measurement of intraoperative PTH 20 minutes after surgery.

Methods

Between 2003 and 2012, 188 patients underwent a focused parathyroidectomy associated to rapid intraoperative PTH assay monitoring. Blood samples were collected: 1) at pre-incision time, 2) at 10 min after gland excision and 3) at 20 min after excision, if a sufficient reduction of PTH value was not observed. On the bases of the Irvin criterion, an intra-operative PTH drop>50% from the highest either pre-incision or pre-excision level after parathyroid excision was considered a surgical success.

Results

A >50% decrease of PTH after gland excision compared to the highest pre-excision value occurred in 156/188 patients (83%) within 10 min and in further 12/188 after 20 minutes (6.4%). In the remaining 20 patients (10.6%) values of PTH remained substantially unchanged or decreased less than 50% and for this reason bilateral neck exploration was performed. An additional pathologic parathyroid was removed in 9 cases, a third in one. In the other 10 cases further neck exploration by a standard cervical approach was negative and in four of these persistent postoperative hypercalcemia was demonstrated. The overall operative success was 97.3%. Intraoperative PTH monitoring was accurate in predicting operative success or failure in 96.3% of patients.

Conclusions

The 20 minutes PTH measurement appears very useful, avoiding unnecessary bilateral exploration and the related risk of complications with only a slight increase of the duration of surgery and of the costs. PTH values decreasing appeared to be influenced by surgical manipulations during minimally invasive parathyroidectomy.

【 授权许可】

   
2013 Calò et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Boi F, Lombardo C, Cocco MC, Piga M, Serra A, Lai ML, Calò PG, Nicolosi A, Mariotti S: Thyroid disease cause mismatch between MIBI scan and neck ultrasound in the diagnosis of hyperfunctioning parathyroids: usefulness of FNA-PTH assay. Eur J Endocrinol 2013, 168:49-58.
• [2]Philips IJ, Kurzawinski TR, Honour JW: Potential pitfalls in intraoperative parathyroid hormone measurements during parathyroid surgery. Ann Clin Biochem 2005, 42:453-458.
• [3]Calò PG, Pisano G, Tatti A, Medas F, Boi F, Mariotti S, Nicolosi A: Intraoperative parathyroid hormone assay during focused parathyroidectomy for primary hyperparathyroidism: is it really mandatory? Minerva Chir 2012, 67:337-342.
• [4]Di Stasio E, Carrozza C, Lombardi CP, Raffaelli M, Traini E, Bellantone R, Zuppi C: Parathyroidectomy monitored by intra-operative PTH: The relevance of the 20 min end-point. Clin Biochem 2007, 40:595-603.
• [5]Thier M, Nordenström E, Bergenfelz A, Westerdahl J: Surgery for patients with primary hyperparathyroidism and negative sestamibi scintigraphy - a feasibility study. Langenbecks Arch Surg 2009, 394:881-884.
• [6]Yang GP, Levine S, Weigel RJ: A spike in parathyroid hormone during neck exploration may cause a false-negative intraoperative assay result. Arch Surg 2001, 136:945-949.
• [7]Bieglmayer C, Prager G, Niederle B: Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy. Clin Chem 2002, 48:1731-1738.
• [8]Elaraj DM, Sippel RS, Lindasy S, Sansano I, Duh QY, Clark OH, Kebebew E: Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results. Arch Surg 2010, 145:578-581.
• [9]Calò PG, Tatti A, Medas F, Piga G, Farris S, Pisano G, Nicolosi A: Nuove tecniche nella chirurgia delle paratiroidi. G Chir 2010, 31:322-324.
• [10]Riss P, Kaczirek K, Bieglmayer C, Niederle B: PTH spikes during parathyroid exploration – a possible pitfall during PTH monitoring? Langenbecks Arch Surg 2007, 392:427-430.
• [11]Westerdahl J, Bergenfelz A: Parathyroid surgical failures with sufficient decline of intraoperative parathyroid hormone levels: unobserved multiple endocrine neoplasia as an explaination. Arch Surg 2006, 141:589-594.
• [12]Barczynski M, Konturek A, Cichon S, Hubalewska-Dydejczyk A, Golkowski F, Husznot B: Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging. Clin Endocrinol 2007, 66:878-885.
• [13]Sebag F, Hubbard JGH, Maweja S, Misso C, Tardivet L, Henry JF: Negative preoperative localization studies are highly predictive of multiglandular disease in sporadic primary hyperparathyroidism. Surgery 2003, 134:1038-1041.
• [14]Catania A, Sorrenti S, Falvo L, Santulli M, Berni A, De Antoni E: Validity and limits of intraoperative rapid parathyroid hormone assay in primary hyperparathyroidism treated by traditional and mini-invasive surgery. Int Surg 2002, 87:226-232.
• [15]Conzo G, Perna AF, Sinisi AA, Palazzo A, Stanzione F, Della Pietra C, Livrea A: Total parathyroidectomy without autotransplantation in the surgical treatment of secondary hyperparathyroidism of chronic kidney disease. J Endocrinol Invest 2012, 35:8-13.
• [16]Gioviale MC, Gambino G, Maione C, Romano G, Damiano G, Cocchiara G, Pirrotta C, Moscato F, Lo Monte AI, Buscemi G, Romano M: Use of monitoring intraoperative parathyroid hormone during parathyroidectomy in patients on waiting list for renal transplantation. Transplant Proc 2007, 39:1775-1778.
• [17]Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL: Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: Which criterion is the most accurate? Surgery 2003, 134:973-981.
• [18]Lombardi CP, Raffaelli M, Traini E, Di Stasio E, Carrozza C, De Crea C, Zuppi C, Bellantone R: Intraoperative PTH monitoring during parathyroidectomy: the need for stricter criteria to detect multiglandular disease. Langenbecks Arch Surg 2008, 393:639-645.
• [19]McGill J, Sturgeon C, Kaplan SP, Chiu B, Kaplan EL, Angelos P: How does the operative strategy for primary hyperparathyroidism impact the findings and cure rate? A comparison of 800 parathyroidectomies. J Am Coll Surg 2008, 207:246-249.